BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16254324)

  • 1. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon.
    Chehadeh W; Lobert PE; Sauter P; Goffard A; Lucas B; Weill J; Vantyghem MC; Alm G; Pigny P; Hober D
    J Virol; 2005 Nov; 79(22):13882-91. PubMed ID: 16254324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells.
    Sauter P; Lobert PE; Lucas B; Varela-Calvino R; Alm G; Wattre P; Hober D
    Virus Res; 2007 May; 125(2):183-90. PubMed ID: 17291618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes.
    Sauter P; Chehadeh W; Lobert PE; Lazrek M; Goffard A; Soumillon M; Caloone D; Vantyghem MC; Weill J; Fajardy I; Alm G; Lucas B; Hober D
    J Med Virol; 2008 May; 80(5):866-78. PubMed ID: 18366069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells.
    Alidjinou EK; Sané F; Engelmann I; Hober D
    J Mol Biol; 2013 Dec; 425(24):5020-31. PubMed ID: 24120940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis.
    Hober D; Chehadeh W; Bouzidi A; Wattré P
    J Infect Dis; 2001 Nov; 184(9):1098-108. PubMed ID: 11598831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes.
    Hober D; Chehadeh W; Weill J; Hober C; Vantyghem MC; Gronnier P; Wattré P
    J Gen Virol; 2002 Sep; 83(Pt 9):2169-2176. PubMed ID: 12185270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro.
    Chehadeh W; Bouzidi A; Alm G; Wattré P; Hober D
    J Gen Virol; 2001 Aug; 82(Pt 8):1899-1907. PubMed ID: 11457996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection.
    Chehadeh W; Weill J; Vantyghem MC; Alm G; Lefèbvre J; Wattré P; Hober D
    J Infect Dis; 2000 Jun; 181(6):1929-39. PubMed ID: 10837172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.
    Chehadeh W; Kerr-Conte J; Pattou F; Alm G; Lefebvre J; Wattré P; Hober D
    J Virol; 2000 Nov; 74(21):10153-64. PubMed ID: 11024144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent enhancement and neutralization against CVB4 investigated in vitro and in silico through an agent-based model.
    Morvan C; Nekoua MP; Debuysschere C; Alidjinou EK; Hober D
    J Med Virol; 2024 Jan; 96(1):e29399. PubMed ID: 38235792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.
    Hober D; Sane F; Jaïdane H; Riedweg K; Goffard A; Desailloud R
    Clin Exp Immunol; 2012 Apr; 168(1):47-51. PubMed ID: 22385236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
    Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
    Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera.
    Reimann BY; Zell R; Kandolf R
    J Virol; 1991 Jul; 65(7):3475-80. PubMed ID: 1645779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65).
    Vreugdenhil GR; Batstra MR; Aanstoot HJ; Melchers WJ; Galama JM
    J Med Virol; 1999 Oct; 59(2):256-61. PubMed ID: 10459165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of the coxsackievirus B4 VP4 capsid protein investigated in silico.
    Goffard A; Sané F; Soumillon M; Hober D
    Discov Med; 2011 Aug; 12(63):153-8. PubMed ID: 21878192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of cross-reactive peptide antibodies against viral capsid proteins of human enterovirus B to apply diagnostic reagent.
    Jeong SY; Ahn J; Cho YJ; Kim YJ; Kim DS; Jee Y; Lee H; Nam JH
    Microbiol Immunol; 2007; 51(11):1091-8. PubMed ID: 18037786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune effects of four coxsackievirus B3 VP1 DNA fusion vaccines in mice].
    Liu GX; Lan JM; Chuai X; Gao ZY; Jin YH; Zhang YH; Xie LX; Yin CF; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):103-6. PubMed ID: 20230664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing and neutralizing anti-coxsackievirus activities in serum samples from patients prior to development of type 1 diabetes.
    Sane F; Bertin A; Sioofy-Khojine AB; Oikarinen S; Alidjinou EK; Veijola R; Toppari J; Ilonen J; Knip M; Engelmann I; Hyöty H; Hober D
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3305. PubMed ID: 32118346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.
    Jrad-Battikh N; Souii A; Oueslati L; Aouni M; Hober D; Gharbi J; Ben M'hadheb-Gharbi M
    Curr Microbiol; 2014 Apr; 68(4):503-9. PubMed ID: 24322405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.